**Background:** Postoperative complications after colorectal surgery remain high, with reported rates from 20% to 60%, and there is no universally accepted standard perioperative protocol for colorectal cancer patients. While ERAS and fast-track surgery pathways have shown benefits, no single protocol comprehensively addresses pre-, peri-, and postoperative steps. This study evaluates a multimodal fail-safe model designed to minimize severe complications following oncologic colorectal resections.
**Methods:** This single-center study at Hospital Reinbek St. Adolf-Stift, Germany, compared a historical control group (January 2013–December 2014, n=186) with a prospectively collected fail-safe group (January 2015–December 2019, n=510). Inclusion required oncologic colorectal resection with primary anastomosis for UICC stage I–IV colorectal cancer. Exclusion criteria were benign lesions, terminal stoma, or associated malignancies. The fail-safe protocol included: preoperative mechanical bowel preparation without oral antibiotics; perioperative single-dose IV antibiotics; standardized surgical technique with an experienced colorectal surgeon (>30 resections with anastomosis/year) always present; complete mesocolic excision with central vascular ligation; complete mobilization of the hemicolon for tension-free anastomosis; bleeding/perfusion testing at the resection margin; side-to-side anastomosis with additional tension-relieving seams or end-to-end anastomosis with specific technical steps (sphincter stretching for 3 minutes, stapler spine positioned next to staple line, compression for ≥1 minute before release); intraoperative sigmoidoscopic assessment with air test for rectal anastomoses; protective ileostomy for all low rectal anastomoses; on-table lavage with 5L saline via efferent ileal loop; pelvic drain placement; 3-day low-volume high-calorie nutrition; and endoscopic anastomosis control on postoperative day 4. The control group was treated with ERAS without preoperative colonic irrigation, routine perfusion testing, routine ileostomy, or on-table lavage. Statistical analysis used chi-square test, t-test, and multivariate logistic regression (IBM SPSS v25).
**Key Results:** Of 924 patients undergoing colorectal operations, 696 met inclusion criteria (427 laparoscopic [61.4%], 230 open [33.0%], 39 conversions [5.6%]). Groups were comparable in age, sex, ASA classification, BMI, and tumor distribution, except for surgical approach (control: 51.6% open vs fail-safe: 26.3% open; p<0.0001). Major complications (Dindo-Clavien ≥3b) reduced from 22.6% (42/186) to 9.8% (50/510) (p<0.0001). Anastomotic leakage decreased from 11.8% (22/186) to 3.7% (19/510) (p<0.0001), with significant reduction in left colon (p=0.047) and low rectal resections (p<0.001), but not right colon (p=0.755). Re-operation rate fell from 18.8% to 6.1% (p<0.0001), wound infection from 18.3% to 5.3% (p<0.0001), and pneumonia from 6.5% to 2.5% (p=0.014). 90-day mortality was similar (2.7% vs 2.4%, p=0.80). Mean postoperative hospital stay was significantly shorter in the fail-safe group (8.9 vs 18.9 days, p<0.0001). Logistic regression confirmed significantly less leakage in the fail-safe group (p<0.000), with AL significantly associated with longer hospital stay (p<0.000), poor 90-day survival (p<0.05), surgical site infection (p<0.000), and re-operation (p<0.000).
**Clinical Implications:** This multimodal fail-safe protocol demonstrates substantial reductions in major complications, anastomotic leakage, re-operations, and wound infections compared to standard ERAS-based care. The comprehensive approach addresses modifiable risk factors across all perioperative phases, with particular benefit for high-risk low rectal anastomoses (AL rate 1.2% for elective cases). Key elements include mandatory experienced surgeon involvement, standardized anastomotic technique with perfusion testing, routine protective ileostomy for low rectal anastomoses, on-table lavage, early endoscopic surveillance, and OTSC-ready management of detected leaks. The protocol is applicable in both elective and emergency settings. Limitations include non-randomized design, single-center setting, larger fail-safe group, potential confounding from laparoscopic technique improvements over time, and inability to determine the independent contribution of each protocol component. Further research is needed to validate individual elements and incorporate emerging technologies like ICG fluorescence imaging.